Phenocell logo — Your partner for finely tuned in vitro R&D solutions | For t...

Phenocell

Your partner for finely tuned in vitro R&D solutions | For the pharmaceutical and dermo-cosmetic industry

Founded 2013 France France 10 employees Biotechnology, Pharmaceutical

General Information

Company Name Phenocell
Founded Year 2013
Location France France
Employees 10
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Phenocell. To contact Phenocell, visit phenocell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phenocell compare?

A PDF of Phenocell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phenocell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phenocell

Phenocell is a biotechnology company founded in 2013 based in France. The company specializes in in vitro R&D solutions for the pharmaceutical and dermo-cosmetic industry. Using Nobel-prize winning technology of cellular reprogramming, Phenocell creates foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. They are known for large batches of qualified cells used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell's areas of expertise include the production of human skin cells such as sebocytes, melanocytes, and keratinocytes, as well as human retinal cells like retinal pigment epithelium cells. They also apply iPSC-derived somatic cells to phenotypic assays. The company positions itself as a designated partner for open innovation projects and emphasizes its role in research and drug discovery. Phenocell offers detailed information about its products and services on www.phenocell.com. Currently, there is no public information available regarding the last investment and the involved investors.

Business keywords: cellular models, drug discovery, cellular reprogramming, hiPSC, phenotypic assays, skin research, ophthalmology, RPE cells, sebocytes, melanocytes, retinal pigment epithelium cells, iPSC-derived somatic cells, dermo-cosmetic industry

No funding data available for Phenocell yet.

Phenocell Alternatives & Competitors

Phenocell vs

The Newcells ophthalmology business was acquired by Axol Bioscience

12 employees
Biotechnology, Health Care
Phenocell vs
Melior Discovery
Melior Discovery United States

Capture the Untapped Value of Therapeutics

Venture round
29 employees
Biopharma, Biotechnology

FAQ About Phenocell

Your partner for finely tuned in vitro R&D solutions | For the pharmaceutical and dermo-cosmetic industry
Phenocell was founded in 2013.
Phenocell is headquartered in France.
Phenocell operates in Biotechnology and Pharmaceutical. Its work centres on cellular models, drug discovery, cellular reprogramming and hiPSC.
Phenocell has approximately 10 employees.
Top alternatives and competitors to Phenocell include Newcells Biotech (Axol Bioscience), Melior Discovery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phenocell and Newcells Biotech (Axol Bioscience) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phenocell, https://bouncewatch.com/company/phenocell, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes